BioCentury
ARTICLE | Clinical News

MA09-hRPE cells: Phase I/II started

January 30, 2012 8:00 AM UTC

Advanced Cell began an open-label, dose-escalation, U.K. Phase I/II trial to evaluate sub-retinal transplantation of 50,000, 100,000, 150,000 and 200,000 MA09-hRPE cells in 12 SMD patients. The produc...